These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29748237)

  • 1. An Overview of PET Radiochemistry, Part 2: Radiometals.
    Brandt M; Cardinale J; Aulsebrook ML; Gasser G; Mindt TL
    J Nucl Med; 2018 Oct; 59(10):1500-1506. PubMed ID: 29748237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects.
    Pandey MK; DeGrado TR
    Curr Radiopharm; 2021; 14(4):325-339. PubMed ID: 32867656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matching chelators to radiometals for radiopharmaceuticals.
    Price EW; Orvig C
    Chem Soc Rev; 2014 Jan; 43(1):260-90. PubMed ID: 24173525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
    Deri MA; Zeglis BM; Francesconi LC; Lewis JS
    Nucl Med Biol; 2013 Jan; 40(1):3-14. PubMed ID: 22998840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classics in Neuroimaging: Shedding Light on Opioid Receptors with Positron Emission Tomography Imaging.
    Kaur T; Wiesner N; Kilbourn MR; Scott PJH
    ACS Chem Neurosci; 2020 Oct; 11(19):2906-2914. PubMed ID: 32970401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 patents (2009-2015). Part 2: new radiochemistry.
    Mossine AV; Thompson S; Brooks AF; Sowa AR; Miller JM; Scott PJ
    Pharm Pat Anal; 2016 Sep; 5(5):319-49. PubMed ID: 27610753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of PET Radiochemistry, Part 1: The Covalent Labels
    Pichler V; Berroterán-Infante N; Philippe C; Vraka C; Klebermass EM; Balber T; Pfaff S; Nics L; Mitterhauser M; Wadsak W
    J Nucl Med; 2018 Sep; 59(9):1350-1354. PubMed ID: 30042159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocatalysis in radiochemistry: Enzymatic incorporation of PET radionuclides into molecules of biomedical interest.
    da Silva ES; Gómez-Vallejo V; López-Gallego F; Llop J
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):332-354. PubMed ID: 29231247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on production of 89Zr in a medical cyclotron for PET radiopharmaceuticals.
    Kasbollah A; Eu P; Cowell S; Deb P
    J Nucl Med Technol; 2013 Mar; 41(1):35-41. PubMed ID: 23327781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium-68: methodology and novel radiotracers for positron emission tomography (2012-2017).
    Tanzey SS; Thompson S; Scott PJ; Brooks AF
    Pharm Pat Anal; 2018 Sep; 7(5):193-227. PubMed ID: 30066605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: effect of solution composition on in-target chemistry.
    Pandey MK; Engelbrecht HP; Byrne JP; Packard AB; DeGrado TR
    Nucl Med Biol; 2014 Apr; 41(4):309-16. PubMed ID: 24607433
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Heskamp S; Raavé R; Boerman O; Rijpkema M; Goncalves V; Denat F
    Bioconjug Chem; 2017 Sep; 28(9):2211-2223. PubMed ID: 28767228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancement in Production of Radiotracers.
    Hansen SB; Bender D
    Semin Nucl Med; 2022 May; 52(3):266-275. PubMed ID: 34836618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
    Webster WD; Parks GT; Titov D; Beasley P
    Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and Use of the First-Row Transition Metal PET Radionuclides
    Chaple IF; Lapi SE
    J Nucl Med; 2018 Nov; 59(11):1655-1659. PubMed ID: 30262514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear data for production and medical application of radionuclides: Present status and future needs.
    Qaim SM
    Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.